Phosphinous and phosphonic acid derivatives used as medicaments
WO0002851A1
Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
WO9955896A1
A new glucose-6-phosphate translocase inhibitor l 970885 from an actinomycete sp., and chemical derivatives thereof, a process for the preparation and their use as pharmaceuticals
WO9955895A1
A new glucose-6-phosphate translocase inhibitor l 970871 from an actinomycete sp., and chemical derivatives thereof, a process for the preparation and their use as pharmaceuticals
AU3413499A
Miniaturized microtiter plate for high throughput screening
DE19856261C1
Detection of gamma-secretase by detection of A-beta peptide useful for determining gamma-secretase activity and for identifying inhibitors
WO9919502A1
Transfection system for the transfer of nucleic acids into cells
Treating male or female sexual dysfunction, especially erectile dysfunction, using propentofylline or corresponding alcohol as selective phosphodiesterase V inhibitor
IL126276D0
The use of an inhibitor of the na+/H+ exchanger for the production of a medicament for the treatment or prophylaxis of disorders of the central nervous system
EP0987274A1
Factor VIIa Inhibitors
DE19841534A1
Treating autonomic nervous system dysfunction, especially vagal dysfunction of the heart, uses new or known benzenesulfonyl (thio)urea derivatives optionally in combination with beta-blockers
DE19841051A1
Treating male or female sexual dysfunction, especially erectile dysfunction, using propentofylline or corresponding alcohol as selective phosphodiesterase V inhibitor
DE19840731A1
Two-color differential display as a method for the detection of regulated genes
DE19838097A1
Process for the chromatographic purification of insulins
DE19836697A1
New substituted 4-amino-2-aryl-pyrimidines, are soluble guanylate cyclase activators useful e.g. for treating atherosclerosis, hypertension, angina pectoris, thrombosis, asthma or diabetes
DE19836505A1
Miniaturized microtiter plate for high throughput screening in e.g. pharmaceutical screening trials e.g. sandwich assays
EP0978561A1
Antisense oligonucleotides for the inhibition of VEGF expression
EP0979869A1
Short oligonucleotides for the inhibition of VEGF expression
DE19834604A1
Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine and 1-(5-hydroxyhexyl)-3-methyl-7-n-propylxanthine as phosphodiesterase V inhibitors to prepare medicaments for treating erectile dysfunction
